Literature DB >> 21818722

[Prefrontal cortex mediated control of expectations in placebo analgesia].

P Krummenacher1.   

Abstract

Expectations and beliefs modulate the experience of pain, which is particularly evident in placebo analgesia. The dorsolateral prefrontal cortex (DLPFC) has been associated with pain regulation and with the generation, maintenance and manipulation of cognitive representations. In a heat-pain paradigm, we employed non-invasive low-frequency repetitive transcranial magnetic stimulation (rTMS) to transiently disrupt left and right DLPFC function or used the TMS device itself as a placebo, before applying an expectation-induced placebo analgesia. The results demonstrated that placebo significantly increased pain threshold and pain tolerance. While rTMS did not affect pain experience, it completely blocked placebo analgesia. These findings suggest that expectation-induced placebo analgesia is mediated by symmetric prefrontal cortex function. Possible implications for medical practice and clinical trial research will be discussed in the article.

Entities:  

Mesh:

Year:  2011        PMID: 21818722     DOI: 10.1007/s00482-011-1049-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  19 in total

1.  Placebo and opioid analgesia-- imaging a shared neuronal network.

Authors:  Predrag Petrovic; Eija Kalso; Karl Magnus Petersson; Martin Ingvar
Journal:  Science       Date:  2002-02-07       Impact factor: 47.728

2.  Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation.

Authors:  Uwe Herwig; Peyman Satrapi; Carlos Schönfeldt-Lecuona
Journal:  Brain Topogr       Date:  2003       Impact factor: 3.020

3.  Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging.

Authors:  Jian Kong; Randy L Gollub; Ilana S Rosman; J Megan Webb; Mark G Vangel; Irving Kirsch; Ted J Kaptchuk
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

Review 4.  Is there a future for therapeutic use of transcranial magnetic stimulation?

Authors:  Michael C Ridding; John C Rothwell
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

Review 5.  Neurocognitive aspects of pain perception.

Authors:  Katja Wiech; Markus Ploner; Irene Tracey
Journal:  Trends Cogn Sci       Date:  2008-07-05       Impact factor: 20.229

Review 6.  Biological, clinical, and ethical advances of placebo effects.

Authors:  Damien G Finniss; Ted J Kaptchuk; Franklin Miller; Fabrizio Benedetti
Journal:  Lancet       Date:  2010-02-20       Impact factor: 79.321

Review 7.  Overt versus covert treatment for pain, anxiety, and Parkinson's disease.

Authors:  Luana Colloca; Leonardo Lopiano; Michele Lanotte; Fabrizio Benedetti
Journal:  Lancet Neurol       Date:  2004-11       Impact factor: 44.182

8.  Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems.

Authors:  M Amanzio; F Benedetti
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

9.  Prefrontal cortex modulates placebo analgesia.

Authors:  Peter Krummenacher; Victor Candia; Gerd Folkers; Manfred Schedlowski; Georg Schönbächler
Journal:  Pain       Date:  2009-10-28       Impact factor: 6.961

10.  The mechanism of placebo analgesia.

Authors:  J D Levine; N C Gordon; H L Fields
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

View more
  2 in total

1.  From cue to meaning: brain mechanisms supporting the construction of expectations of pain.

Authors:  Oleg V Lobanov; Fadel Zeidan; John G McHaffie; Robert A Kraft; Robert C Coghill
Journal:  Pain       Date:  2013-09-17       Impact factor: 6.961

2.  Placebo, nocebo: Believing in the field of medicine.

Authors:  Karin Meissner
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.